3.1 Treatment success after initial treatment |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
3.1.1 Suction curettage after UAE |
1 |
66 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.91 [0.81, 1.03] |
3.1.2 Suction curettage after UACE |
1 |
92 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.02 [0.96, 1.09] |
3.2 Complications |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
3.2.1 Suction curettage after UAE |
1 |
66 |
Risk Ratio (M‐H, Fixed, 95% CI) |
4.00 [0.47, 33.91] |
3.2.2 Suction curettage after UACE |
1 |
92 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.18 [0.01, 3.72] |
3.3 Adverse effects (overall) |
2 |
|
Odds Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
3.3.1 Suction curettage after UAE |
1 |
66 |
Odds Ratio (M‐H, Fixed, 95% CI) |
3.09 [0.12, 78.70] |
3.3.2 Suction curettage after UACE |
1 |
92 |
Odds Ratio (M‐H, Fixed, 95% CI) |
Not estimable |
3.4 Time to normalize β‐hCG |
2 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
3.4.1 Suction curettage after UAE |
1 |
66 |
Mean Difference (IV, Fixed, 95% CI) |
4.03 [‐1.79, 9.85] |
3.4.2 Suction curettage after UACE |
1 |
92 |
Mean Difference (IV, Fixed, 95% CI) |
0.84 [‐1.90, 3.58] |